A series of 27 cinchona alkaloid derivatives (1f-w, 2a-e and 3a-d) were investigated for their cytotoxic and trypanocidal activities using seven different cancer cell 
| INTRODUCTION
The bark of the cinchona tree (Cinchona sp.) contains many bioactive quinoline-type alkaloids. Among them, quinine is both the most important and best known alkaloid of this class of natural compounds. Historically, quinine was the sole cure for malaria for centuries until the introduction of the synthetic analogue chloroquine after World War II. Other major alkaloids found in the cinchona bark are the closely related compounds quinidine, cinchonine and cinchonidine, which together with quinine are collectively classified as "cinchona alkaloids."
Apart from their utilisation as anti-malaria agents, cinchona alkaloids are also deployed to treat intestinal parasites, arrhythmia and other heart conditions, nocturnal leg cramps, and fever, and are used as a bitter digestive aid. [1, 2] In addition, cinchona alkaloids have been reported to be inhibitors of the P-glycoprotein, a membrane transporter that is overexpressed on tumour cells and responsible for the process of efflux of chemotherapeutics. For example, cinchonine has been shown to improve the accumulation of doxorubicin in cancer cells. [3] Moreover, cinchonine and quinine were found to induce apoptosis in cancer cells and thus inhibit their proliferation. [4, 5] Furthermore, cinchona alkaloids have been reported to display trypanocidal activity against bloodstream forms of Trypanosoma brucei and T. congolense with 50% growth inhibition (GI 50 ) values in the mid-to low-micromolar range. [6] These flagellated protozoan parasites are the causative agents of sleeping sickness in humans and nagana disease in cattle, and are transmitted by the bite of infected tsetse flies. African trypanosomiasis is one of the most neglected tropical diseases and throughout history, it has severely repressed the economic and cultural development of central Africa.
T A B L E 1 Chemical structure of cinchona alkaloids (1a-e) and their derivatives (1f-w, 2a-e, 3a-d) 
As the few currently available chemotherapies of sleeping sickness and nagana disease are unsatisfactory, [8] new and effective drugs are needed for treatment of African trypanosomiasis. The previous findings that native cinchona alkaloids have anti-cancer and anti-trypanosomal properties prompted us to investigate whether the cytotoxic and trypanocidal activities of this class of natural products can be improved by their modification. In this study, we report the cytotoxic and trypanocidal activities of 27 cinchona alkaloid derivatives (Table 1) of which 8 were commercially available (1f-h, 2a-e) and 19 were synthesised (1i-w, 3a-d) according to published methods. [9] [10] [11] [12] [13] [14] [15] [16] 
| METHODS AND MATERIALS

| Reagents
Unmodified cinchona alkaloids 1a-e and their hydrogenated analogues 1f-h and 1k were purchased from Buchler GmbH (Braunschweig, Germany) or Sigma-Aldrich (Poznan, Poland). 9-Amino-9-epi-cinchona derivatives 2a-d and the thiourea 2e were bought from AdvaChemLab (Poznan, Poland). All other reagents required for organic synthesis and toxicity assays were obtained from SigmaAldrich (Poznan, Poland and Gillingham, UK, respectively) and Fluorochem (Hadfield, UK) and used as received.
| Chemistry
NMR spectra were recorded at 295 K on a Bruker Ascend 400 MHz spectrometer, operating at frequencies of 400 MHz for 1 H and 101 MHz for 13 C. All shifts were referenced to the internal tetramethylsilane. Mass spectra were determined on a Bruker Impact HD instrument. IR spectra were recorded using KBr pellets on a Brucker FT-IR IFS-66/s spectrometer. Dihydrocupreines 1i-j, 10,11-didehydrocinchona alkaloids 1l-m, cinchotenine derivatives 1n-p and deoxyhydroquinidine 1q were prepared as previously described. [9] [10] [11] [12] Quinine esters 1r-s and 9-O-carbamates 1t-w were synthesised using general procedures. [13, 14] Quaternary ammonium salts 3a-c were prepared by reaction of quinine with 9-anthracenylmethyl chloride or appropriate benzyl halides as previously reported while the salt 3d was obtained following a previous published protocol. [15, 16] All compounds were properly characterised and their purity was >95%. Each medium was supplemented with 10% foetal bovine serum, 1% L-glutamine and 1% penicillin/streptomycin solution (final concentrations 100 U/ml penicillin and 100 μg/ml streptomycin). All cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 .
| Cells
For determining the cytotoxic activity of test compounds, the protein-staining sulforhodamine B (SRB) assay and/or the tetrazolium reduction (MTT) assay were employed. Both assays have been assessed by the National Cancer Institute (USA) as suitable for in vitro anti-tumour screening. [17] The SRB and the MTT assay estimate cell densities based on measurement of cellular protein content and activity of oxidoreductase enzymes, respectively. For the SRB assay, 100 μl of diluted cell suspension containing approximately 10 4 cells was added to the wells of 96-well plates. After 24 hr, when a partial monolayer had formed, the supernatant was aspirated and 100 μl medium containing test compounds at six different concentrations (0.1, 0.2, 1, 2, 10 and 20 μg/ml) was added to the cells. Stock solutions of test compounds were prepared in DMSO and the concentration of DMSO in the assay did not exceed 0.1% which was found to be non-toxic to the different cell lines. After incubation for 72 hr, 25 μl of 50% trichloroacetic acid was added to each well and the plates were incubated for 1 hr at 4°C. Thereafter, the plates were washed with distilled water to remove traces of medium and air-dried. Then, the dried plates were stained with 100 μl 0.4% SRB (prepared in 1% acetic acid) for 30 min at room temperature. Unbound dye was removed by rapidly washing with 1% acetic acid and the plates were air-dried overnight. Finally, the protein-bound dye was dissolved in 100 μl of 10 mM unbuffered Tris and the absorbance read at 490 nm. For the MTT assay, 180 μl of suspended cells (2 × 10 4 / ml) was pipetted into the wells of 96-well plates. After 24 hr incubation, 20 μl of test compounds was added (final concentrations of 0.1, 0.2, 1, 2, 10 and 20 μg/ml) and the plates were incubated for another 48 hr. Then, 10 μl of 5 mg/ml MTT solution was added to each well and the plates incubated for additional 3 hr. The formed formazan crystals were dissolved in 100 μl 10% sodium dodecyl sulphate (SDS) solution and the absorbance measured at 545 nm. The concentration of a compound required to inhibit cell growth by 50% (half-maximal growth inhibition; GI 50 ) compared to the control was calculated using graphpad prism software.
| Trypanosomes and HL-60 cells
Bloodstream forms of the non-human pathogenic subspecies T. b. brucei (clone 427-221a [18] ) and human myeloid leukaemia HL-60 cells [19] were grown in Baltz medium [20] supplemented with 16.7% heat-inactivated bovine serum at 37°C in a humidified atmosphere. Toxicity assays with trypanosomes and HL-60 cells were carried out as previously described [6] with some modifications. In brief, cells were seeded in 96-well plates in a final volume of 200 μl of Baltz medium containing test compounds serially diluted 10-fold from 100 μM down to 100 pM and 1% DMSO. Wells just containing medium and 1% DMSO served as controls. The initial cell densities were 1 × 10 4 /ml for trypanosomes and 5 × 10 4 /ml for HL-60 cells. After 24 hr incubation, 20 μl of a 0.5 mM resazurin solution prepared in sterile PBS was added and the cells were incubated for further 48 hr. Thereafter, the absorbance of wells was read at 570 nm (test wavelength) and 630 nm (reference wavelength). The GI 50 value, that is, the concentration of a compound necessary to reduce the growth rate of cells by 50% compared to the control was determined by linear interpolation as described previously. [21] The minimum inhibitory concentration (MIC) values, that is, the concentration of the drug at which all trypanosomes and human cells were killed, was determined microscopically.
| Apoptosis assay
The induction of apoptosis by test compounds was determined with the Cell Death Detection ELISA PLUS from Roche Diagnostics GmbH (Mannheim, Germany). This is an enzyme immunoassay for the determination of cytoplasmic histoneassociated DNA fragments (mono-and oligonucleotides) after induced cell death. Cells (10 4 ) were pipetted into wells of 96-well plates and test compounds added at final concentrations of 0.1, 1 and 10 μg/ml. Cells incubated in the absence of test compounds served as negative controls. After 4 hr incubation, cells were harvested by centrifugation of the plates for 10 min at 200 × g. Supernatants were removed carefully and cell pellets re-suspended in 200 μl lysis buffer and incubated for 30 min at room temperature. After centrifugation of the plates (10 min, 200 × g), 20 μl of cell lysates was transferred in duplicate into wells of provided streptavidin-coated microplates. Then, 80 μl of the immunoreagent containing a mixture of anti-histone-biotin monoclonal antibody and anti-DNA-peroxidase monoclonal antibody was added to each well. The microplates were covered with a provided adhesive foil and incubated for 2 hr at room temperature. Thereafter, the solution in the wells was removed by tapping the microplate. The wells were rinsed three times with incubation buffer and 100 μl of substrate (2,2′-azino-bis(3-ethylbenzot hiazoline-6-sulphonic acid, ABTS) was added to each well. After 10-20 min, 100 μl of ABTS stop solution was pipetted to each well and the absorbance was read at 405 nm (test wavelength) and 490 nm (reference wavelength). The apoptotic index was calculated based on the enrichment of mono-and oligonucleosomes according to the following equation:
T A B L E 2
3 | RESULTS AND DISCUSSION
| Cytotoxicity of cinchona alkaloid derivatives
The cytotoxic activities of unmodified (1a-e) and derivatised (1f-u, 1w, 2a-c, 2e, 3d) cinchona alkaloids were evaluated with six human tumour cell lines (KB: cervix carcinoma derived from HeLa cells a ; HeLa: cervix carcinoma; MCF-7: breast cancer; A-549: lung cancer; Hep-G2: liver cancer; U-87, glioblastoma) and two normal cell lines (HDF: human dermal fibroblast; CHO: Chinese hamster ovary cells) using the SRB and/or the MTT assay. The unmodified cinchona alkaloids 1a-c were not very cytotoxic with GI 50 (half-maximal growth inhibition) values ranging from 36.4 to 155 μM for tumour cells and from 111 to 397 μM for normal cells (Table 2) . Similar cytotoxicity values have been previously reported for quinine and KB cells (GI 50 = 118 μM; our study 55.5 μM) and for cinchonine and HeLa cells (GI 50 = 180 μM; our study 155 μM). [4, 5] Cinchona alkaloid molecules with an ethyl, an ethynyl or a carboxyl group (1f-p) instead of the vinyl group displayed similar cytotoxic activities as their unmodified counterparts (Table 2 ). This finding suggests the vinyl group to be non-essential to the cytotoxic action of cinchona alkaloids. On the other hand, some compounds with a modified C-9 hydroxy group showed improved cytotoxicities compared to the unmodified precursors. While compounds without a C-9 hydroxy group (1q) or with an esterified C-9 hydroxy group (1r-s) did not show increased cytotoxic activities, two 9-O-carbamates (1u and 1w) displayed improved cytotoxicities with GI 50 values in the low-micromolar range (Table 2) . A 9-O-allyl cinchonidine derivative (3d) which was additionally quaternised at the quinuclidine nitrogen with a bulky 9-methylanthracene substituent (note that single modification of this position with a 9-methylanthracene substituent (3a) already increases the cytotoxic activity of cinchona alkaloids slightly; see below and Table 4 ) exhibited cytotoxic activities with GI 50 values in the low-micromolar range as well (Table 2) . Furthermore, compounds with a C-9 amino group of inverted absolute configuration instead of the native C-9 hydroxy group (2a-c) showed slightly improved cytotoxic activities (~4-fold lower GI 50 value; Table 2 ). A 9-amino-9-epi-quinidine derivative in which the amino group was transformed into a 3,5-bis(trifluoromethyl) phenylthiourea substituent (2e) exhibited further enhanced cytotoxicity with GI 50 values in the low-and mid-micromolar range for tumour and normal cells, respectively (Table 2) . Derivatives 1u, 1w, 2e and 3d were identified as the most toxic compounds for all cancer cells with GI 50 values <10 μM. As the reliability of cytotoxic assays is linked to the mode of action of the drug and the employed test methods, we also evaluated the cytotoxic activity of the four compounds with the MTT cell proliferation assay. While the MTT assay gave higher GI 50 values for 1u, 1w and 3d, the SRB assay gave higher GI 50 values for 2e ( Table 2) . As both methods (SRB and MTT) gave GI 50 values of the same order of magnitude (1-10 μM), it can be concluded that the determined concentration range is the effective level of cytotoxicity of the four compounds.
In comparison to cytarabine and doxorubicin (reference drugs), two currently used conventional anti-cancer drugs, the four most cytotoxic compounds 1u, 1w, 2e and 3d displayed lower cytotoxicities (Table 2 ). Based on the results obtained by the MTT assay, only compound 2e approximated the cytotoxic level of doxorubicin. However, a previous report showed that cytarabine displayed lower cytotoxic activity with GI 50 values of 3-5 μM when determined with the SRB assay. [22] Based on this, it can be assumed that the four compounds exhibited similar cytotoxic activity levels as compared with cytarabine. Overall, tumour cells were found to be more sensitive to all of the compounds tested than normal cells (Table 2 ). This observation indicates that cinchona alkaloid derivatives interfere with the replication of rapidly dividing cancer cells that are generally more susceptible to mitotic reagents than slow dividing normal cells. It is most likely that the compounds that cause DNA damage lead to cell death by apoptosis (see Section 3.2). To determine the selectivity for the four most cytotoxic derivatives 1u, 1w, 2e and 3d, selectivity indices (SIs) were calculated as the ratio of the GI 50 on the normal HDF cell line to the GI 50 on the respective tumour cell line (Table 3) . We calculated the SI only for 1u, 1w, 2e and 3d because these four compounds fulfil the pre-screen criterion for new anti-cancer agents according to the National Cancer Institute (predetermined threshold inhibition concentration of 10 μM). [23] As cytotoxic compounds are usually not very selective, an SI of >3 is generally considered to be good. [24, 25] the SRB assay, the derivatives 1u and 2e displayed SI values that were close to or greater than 3 for the four tumour cell lines tested (Table 3) suggesting that both compounds could be interesting candidates for further drug development. Derivative 1w had SI values less than 3 for the four tumour cell lines (Table 3 ), indicating that this compound exhibited some general toxicity. The quaternary ammonium salt 3d had a surprisingly high SI value for the lung cancer cell line A-549 only (Table 3 ). The SI values calculated from the data of the MTT assay were generally lower. Only 2e had an SI value of >2 for HeLa and A-549 cells (Table 3) . On the other hand, the reference drugs cytarabine and doxorubicin showed SI values slightly higher than 2 for five tumour cell lines tested.
| Induction of apoptosis by compounds 1u, 1w, 2e and 3d
Since cinchona alkaloids have been shown to be able to trigger apoptosis in cancer cells, [5, 26] we were wondering whether the cytotoxic action of the four most potent derivatives was due to the induction of programmed cell death. The ability of compounds 1u, 1w, 2e and 3d to induce apoptosis was investigated with five cancer cell lines (HeLa, KB, A-549, U-87 and Hep-G2). Cells were treated with three different concentrations of each compound (0.1, 1 and 10 μg/ml) and fragmentation of DNA as indicator for apoptosis was determined using a cell death ELISA. All four compounds induced apoptosis to a similar extent in all five cancer cell lines (Figure 1 ). The selectivity index (SI) is defined as the ratio of the GI 50 on the normal cell line HDF to the GI 50 on the respective cancer cell line and were calculated from GI 50 values shown in Table 2 . An SI >1.0 indicates that the compound has a greater activity against tumour cells than against normal cells. A significant increase in the apoptotic index was found for all compounds with increasing concentration indicating that the induction of apoptosis was dose-dependent. At the lower concentrations of 0.1 and 1 μg/ml, 3d was the most effective compound in inducing apoptosis with mean apoptotic indices of 1.77 and 3.92, respectively. At the higher concentration of 10 μg/ml, 2e proved to be the most potent apoptosis-inducing derivative with a mean apoptotic index of 6.97.
T A B L E 3
Although the underlying mechanisms of the derivatives in triggering apoptosis in cancer cells remains unknown, studies with their unmodified counterparts may provide some clues to possible modes of action. For example, cinchona alkaloids have been shown to intercalate into DNA which can trigger apoptosis. [26] Cinchonine has been reported to induce programmed cell death in cancer cells through competitive binding of TRAF6 leading to subsequent inhibition of AKT and TAK1 signalling pathways. [5] Quinine was found to trigger its apoptotic effect through the inhibition of the NF-κB signalling pathway via reduction of Bcl2 and mutant p53 and simultaneous up-regulation of caspase-3 and Bax.
[27]
| Trypanotoxicity of cinchona alkaloid derivatives
Since compounds that display anti-cancer activity often also exhibit trypanocidal activity, [28] we tested the cinchona alkaloid derivatives for their activity to inhibit the growth of bloodstream forms of T. b. brucei as well. The unmodified cinchona alkaloids 1a-d (quinine, quinidine, cinchonine and cinchonidine, respectively) showed similar anti-trypanosomal activities with GI 50 values in the low-to mid-micromolar range and MIC values of 10 to 100 μM as previously reported (Table 4) . [6, 29] Most derivatives displayed similar or lower trypanocidal activity than their unmodified counterparts (Table 4) . Exceptions were compounds 1n, 1o and 2a, which showed no activity against trypanosomes with MIC and GI 50 values >100 μM, and compounds 2e and 3d, which exhibited enhanced trypanocidal activity with MIC values below 10 μM and GI 50 values in the sub-micromolar range (Table 4) . When compared with the MIC value and the GI 50 value of suramin (Table 4 ; reference drug), one of the drugs used in the treatment of sleeping sickness, compounds 2e and 3d were, however, about 10 times less trypanocidal. Interestingly, these two compounds were among the four derivatives that were highly active against the six cancer cell lines (see Table 2 ). The selectivity of the cinchona alkaloid derivatives was determined with human leukaemia HL-60 cells because their sensitivity for approved trypanocides is well established. [6, 30] Most compounds including the unmodified cinchona alkaloids showed no cytotoxicity against HL-60 cells (Table 4) . Only compounds 1s, 1u, 1v, 1w, 2e, 3a and 3d displayed different levels of cytotoxic activity against the leukaemia cells with GI 50 values in the midto low-micromolar range. As the most trypanocidal compounds 2e and 3d were also quite cytotoxic for HL-60 cells, their SI were only moderate (just below 10) (Table 4) . For comparison, drugs used for treatment of sleeping sickness have much higher SIs. [6, 30] For example, the reference drug suramin displayed no cytotoxicity towards HL-60 cell and accordingly the MIC and GI 50 ratios of this trypanocide were >1,000 and >2,941, respectively (Table 4) . However, as HL-60 cells are cancer cells, the selectivity of the two compounds may be overestimated. In fact, the most trypanocidal compound 2e was 1.5-6 times less cytotoxic towards non-malignant HDF cells than towards HL-60 cells (Tables 2 and 4 ). Based on this, the selectivity index of compound 2e would be 15-60. Hence, derivative 2e almost fulfils the activity criteria for drug candidates for African trypanosomiasis (GI 50 < 1 μM; SI > 100).
[31]
| CONCLUSIONS
This investigation has shown that naturally occurring cinchona alkaloids can be considered a source for an easy construction of derivatives with increased cytotoxic and trypanocidal activity. Of the four compounds (1u, 1w, 2e and 3d) that displayed remarkable cytotoxicity, two derivatives (2e and 3d) exhibited also strong anti-trypanosomal activity. The common structural feature of all four compounds was the replacement of their C-9 hydroxy group to either O-carbamates (1u and 1w), to thiourea (2e), or to O-allyl ether (3d). Thus, it seems that appropriate modification of the C-9 hydroxy group is crucial for improving the anti-proliferative activity of cinchona alkaloid derivatives. In addition, a particular stereochemistry of the alkaloid moiety is not a prerequisite for the activity as three (1u, 1w and 3d) out of the four compounds had 8S,9R configuration (as in quinine or cinchonidine) but the 9-epimeric compound 2e with 8S,9S configuration displayed also high potency. Both 9-O-protected quaternary salts and 9-thiourea derivatives turned out to be the promising candidates for further activity optimisation. Studies in this area are in progress and will be presented in due course.
